Tang Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

Tang Capital Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-74,265	Closed	-$3.49M	–	206
2025 Q2	$3.49M	Hold	74,265	–	–	0.18%	101
2025 Q1	$3.28M	Hold	74,265	–	–	0.18%	96
2024 Q4	$2.68M	Hold	74,265	–	–	0.18%	94
2024 Q3	$2.38M	Buy	+74,265	New	+$2.77M	0.17%	96
2024 Q1	–	Sell	-100,000	Closed	-$3.65M	–	129
2023 Q4	$3.65M	Buy	+100,000	New	+$2.61M	0.34%	68
2022 Q4	–	Sell	-120,000	Closed	-$3.42M	–	103
2022 Q3	$3.42M	Buy	+120,000	New	+$3.44M	0.42%	52

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Tang Capital Management's SWTX Position: Q3 2025 in Review

Tang Capital Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 74,265 shares — an estimated $3.49M sold.

Tang Capital Management first reported a position in SWTX in Q3 2022 and held it in 6 quarters. The position peaked at $3.65M in Q4 2023. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Tang Capital Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Tang Capital Management sold 74,265 SpringWorks Therapeutics shares in Q3 2025, an estimated $3.49M.
Tang Capital Management first reported a position in SpringWorks Therapeutics in Q3 2022 and held it in 6 quarters.
Tang Capital Management's SpringWorks Therapeutics position peaked at $3.65M in Q4 2023.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Tang Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.